Apt Pharmaceuticals
APT Pharmaceuticals is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation. The company has successfully enrolled a large, multi-center Phase clinical trial evaluating the effect of CIS on chronic rejection and is preparing for commercialization of the product in the US and Europe.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
7
11 to 50 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Apt Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
Showing 1 of 6 verified contacts
Top roles at Apt Pharmaceuticals
6 distinct titles indexed · top 6 shown.
- 1accounting officer
- 1apt pharma
- 1managing director
- 1senior quality technician
- 1vice president
- 1助理
Sign up to unlock all 6 contacts at Apt Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Apt Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.